Astım–KOAH Overlap Sendromu

Kronik obstrüktif akciğer hastalığı (KOAH ) ve astım en sık görülen kronik akciğer hastalıklarıdır. Dünya genelinde ortalama oniki kişiden birinde astım veya KOAH görülmektedir. KOAH ve astım havayolu obstrüksiyonu, kronik havayolu inflamasyonu ile karakterizedir. Bir kişide hem astım hem KOAH klinik belirtileri beraber bulunuyorsa, Astım-KOAH Overlap Sendromu olarak tanımlanmaktadır. Astımlı hastada persistan hava akımı kısıtlaması ve sigara öyküsü varsa veya KOAH' lı hastada çocukluk çağı astım öyküsü var, solunum fonksiyon testlerinde reverzibilite ve hava yolu inflamasyonunda eozinofili bulunması durumunda Astım-KOAH Overlap Sendromu düşünülmelidir. Bu makalede Astım-KOAH Overlap Sendromunun klinik özellikleri ve tedavisinin aktarılması amaçlanmıştır

Asthma–COPD Overlap Syndrome

Chronic obstructive pulmonary disease (COPD) and asthma are the most common chronic pulmonary disorders. One in every twelve persons worldwide have asthma or COPD. COPD and asthma are characterized by airway obstruction and chronic airway inflammation. When there are both signs and symptoms of both asthma and COPD in a person, this condition is called Asthma-COPD Overlap Syndrome. Asthma-COPD Overlap Syndrome should be considered when an asthmatic person has persistent airflow limitation and smoking history, or when a person with COPD has a history of childhood asthma and shows reversibility in respiratory function tests and eosinophilia in airflow inflammation. The aim of this article is to describe clinical features and treatment of Asthma-COPD Overlap Syndrome

PDF

___

1. Global Initiative for Asthma. Global Strategy for Diagnosis, Management and Prevention of Asthma,2016. Available from:www.ginasthma org. Accessed at May 2017.
2. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2017. Available from: www.goldcopd.org. Accessed at May2017.
3. Şen E, Oğuzülgen IK, Bavbek S, Günen H, Kıyan E, Türktaş H et al. Asthma-COPD overlap syndrome.Tuberk Toraks . 2015;63:265-77.
4. Mauad T, Dolhnikoff M. Pathologic similarities and differences between asthma and chronic obstructive pulmonary diseases.Curr Opin Pulm Med. 2008;14:31-8.
5. Tho NV, Park HY, Nakano Y. Asthma COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology.2016;21:410-8.
6. Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways disease. Lancet Respir Med. 2015;3:719-28
7. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M et al. The coexistence of asthma and Chronic Obstructive Pulmonary Disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.PLoS One 2013;8:e62985.
8. Hardin M, Silverman EK, Barr RG, Hansel NH, Schroeder JD, Make BJ et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
9. Menezes AM, Montes de Oca M, Pérez-Padilla R Nadeau G, Wehrmeister FC,Lopez-Varela MV et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297–304.
10. Zeki AA, Schivo M, Chan A, Albertson TE, Louie S. The Asthma-COPD Overlap Syndrome: a common clinical problem in the elderly. J Allergy (Cairo) 2011;2011:861926.
11. Miravitlles M, Soriano JB, Ancochea J, Munoz L, Duran-Tauleria E, Sánchez G et al. Characterisation of the overlap COPD-asthma phenotype: focus on physical activity and health status. Respir Med.2013;107:1053-60.
12. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest.2003;124:474-81.
14. Fujimoto K, Kubo K, Yamamoto H, Yamaquchi S, Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. 1999;115:697–702.
15. Kitaguchi Y, Konatsu Y, Fujimoto K, Hanaoka M, Kubo K. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma. Int J Chron Obstruct Pulmon Dis. 2012;7: 283–9.
16. Bobolea I, Barranco P, Del Pozo V, Romero D, Sanz V, Lopez-Carrasco V et al. Sputum periostin in patients with different severe asthma phenotypes. Allergy.2015;70:540–6.
17. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF et al. Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking. Am J Respir Crit Care Med. 2005;171:109-14.
18. Tashkin DP. Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications. Curr Opin Pulm Med. 2013;19:116-24.
19. Shi W, Bellusci S, PhD, Warburton D. Lung development and adult lung diseases. Chest. 2007;132:651-6.
20. Postma DS, Kerkhof M, Boezen HM, Koppelman G. Asthma and chronic obstructive pulmonary disease: common genes, common environments? . Am J Respir Crit Care Med. 2011;183:1588-94.
21. Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2013;7:161-73.
22. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax.2009;64:728-35.
23.Orie NGM, Sluiter HJ. Bronchitis: an International Symposium. Assen, Netherlands, Royal van Gorcum,1961.
24. Postma DS, Boezen HM. Rationale for the Dutch hypothesis: allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest.2004:126(Suppl2):96S-104S.
25. Fattahi F, ten Hacken NH, Löfdahl CG, Hykema MN, Timens W,Postma DS et al. Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study. Respir Res. 2013;14:10.
26. Jamieson DB, Matsui EC, Belli A, McCormack MC, Peng E, Pierre-Louis S et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188:187-92.
27. Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest. 1978;73:389- 96.
28. Matsunaga K, Ichikawa T, Oka A, Morishita Y, Kanai K, Hiramatsu M et al. Changes in forced expiratory volume in 1 second over time in patients with controlled asthma at baseline. Respir Med.2014;108:976-82.
29. Postma DS, Rabe KF. The Asthma–COPD Overlap Syndrome. N Engl J Med. 2015;373:1241-9. Arşiv Kaynak Tarama Dergisi . Archives Medical Review Journal Kırıcı Berber ve Kılıç 481
30. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30:452-6.
31. Amelink M, de Nijs SB, Berger M, Weersink EJ, ten Brinke A, Sterk PJ et al. Non-atopic males with adult onset asthma are at risk of persistent airflow limitation. Clin Exp Allergy. 2012;42:769-74.
32. Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010;125:830-7.
33. Bumbacea D, Campbell D, Nguyen L, Carr D, Barnes PJ, Robinson D, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J.2004;24,122-8.
34. GEMA 40. Guía Española para el manejo del asma. 2015. Available at http://www.gemasma.com.
35. Soler-Cataluna JJ, Cosio B, Izquierdo JL, Lopez-Campos JL, Marin JM, Aqüero R et al, Consensus document on the Overlap phenotype COPD-Asthma in COPD. Arch Bronconeumol. 2012;48:331-7.
36. Kankaanranta H, Harju T, Kilpeläinen M, Mazur W, Lehto JT, Katajisto M et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116:291-307.
37. Kovlizek V, Chlumsky J, Zindr V, Neumanova K, Zatloukal J, Zak J et al. Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157:189–201.
38. Louie S, Zeki AA, Schivo M, Chan AW, Yoneda KY, Avdalovic M, Morrissey BM et al. The astmaCOPD overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol. 2013;6197-219.
39. Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med.2008;102:50–6.
40. Soler-Cataluna JJ, Cosio B, Izguierdo JL, Lopez-Campos JL, Marin JM, Aguero R, et al. Consensus document on the Overlap Phenotype COPD-Asthma in COPD. Arch Bronchopneumol. 2012;48:331-7.
41. Bujarski S, Parulekar AD, Sharafkhaneh A, Hanania NA. The Asthma COPD Overlap Syndrome (ACOS). Curr Allergy Asthma Rep.2015;15:509.
42. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, KioumisI, Pitsiou G et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6:146-151.
43. Yoshida M, Nakano T, Fukuyama S, Matsumoto T, Eguchi M, Moriwaki A et al. Effects of tiotropium on lung function in severe asthmatics with or without emphysematous changes. Pulm Pharmacol Ther. 2013;26:159-66.
44. Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C et al. What pulmonologists think Arşiv Kaynak Tarama Dergisi . Archives Medical Review Journal 482 Astım-KOAH Overlap Sendromu about the asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015;10:1321-30.
45. Slats A, Taube C. Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma? Ther Adv Respir Dis. 2016;10:57- 71.
46. Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS), 2015. Available from http://www.goldcopd.org/asthma-copd-overlap.html. Accessed at May 2017.